41 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+ Tg(Cebpb-tTA)5Bjd/0 involves: 129S4/SvJae * C57BL/6 * NMRI	decreased liver triglyceride level	J:210545
	decreased susceptibility to diet-induced hepatic steatosis	J:210545
	normal homeostasis/metabolism phenotype	J:213764
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+ Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 involves: 129S4/SvJae * C57BL/6 * CD-1	abnormal osteoblast morphology	J:211215
	abnormal osteoblast physiology	J:211215
	abnormal osteoclast morphology	J:211215
	normal adipose tissue phenotype	J:211215
	decreased body weight	J:211215
	decreased circulating adiponectin level	J:211215
	decreased circulating glucose level	J:211215
	decreased circulating insulin level	J:211215
	decreased gonadal fat pad weight	J:211215
	decreased insulin secretion	J:211215
	improved glucose tolerance	J:211215
	increased bone ossification	J:211215
	increased bone trabecula number	J:211215
	increased bone volume	J:211215
	increased circulating osteocalcin level	J:211215
	increased insulin sensitivity	J:211215
	increased trabecular bone thickness	J:211215
Col1a1tm4(tetO-Jun/Fosl2)Wag/Col1a1+ Tg(Cebpb-tTA)5Bjd/0 involves: 129S4/SvJae * C57BL/6 * NMRI	decreased liver triglyceride level	J:210545
	decreased susceptibility to diet-induced hepatic steatosis	J:210545
Tg(Acta2-cre/ERT2)#Pcn/0 Tgfbr2tm1Karl/Tgfbr2tm1Karl Tg(H2-K-Fosl2,-EGFP)13Wag/0 B6.Cg-Tgfbr2tm1Karl Tg(Acta2-cre/ERT2)#Pcn Tg(H2-K-Fosl2,-EGFP)13Wag	normal cardiovascular system phenotype	J:238723
	lung inflammation	J:238723
	pulmonary fibrosis	J:238723
Tg(H2-K-Fosl2,-EGFP)13Wag/0 B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag	abnormal lung vasculature morphology	J:238723
	lung inflammation	J:238723
	pulmonary fibrosis	J:238723
	vascular smooth muscle hyperplasia	J:238723
Tg(H2-K-Fosl2,-EGFP)13Wag/0 either: 129.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag or B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag	abnormal lung morphology	J:139032
	abnormal pulmonary artery morphology	J:139032
	cardiac fibrosis	J:139032
	esophagus fibrosis	J:139032
	hunched posture	J:139032
	increased bone mass	J:139032
	increased fibrosarcoma incidence	J:139032
	increased lung weight	J:139032
	liver fibrosis	J:139032
	premature death	J:139032
	pulmonary fibrosis	J:139032
	normal renal/urinary system phenotype	J:139032
	respiratory distress	J:139032
	skin fibrosis	J:139032
	stomach fibrosis	J:139032
	tachypnea	J:139032
	thymus fibrosis	J:139032